Daily Brief Archive: August 4, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- Iran de-escalation sent crude down over 5%; risk appetite returned across the board
- Dow hit a record 53,178; S&P 500 +1.48%, Nasdaq +2.1%
- Microsoft added roughly $450B in one session — the largest single-day gain in US history
- Morgan Stanley blessed AI capex; META +6%, GOOGL +4.9%
- Apple bucked the tape at -1.78% as memory inflation bites margins and supply
- AstraZeneca -6.88%: a rumored $400B megamerger was punished, not rewarded
Hong Kong
- Hang Seng +0.48% back above 26,000; HS Tech +0.96%
- Southbound net buying of HK$11.03B rotated back into platforms
- Alibaba +7.01% to 125.2 on the 2.4T-parameter Qwen3.8 launch
- WuXi AppTec lifted FY guidance to RMB58.5–60.5B; A/H shares ripped
- CXO names rallied together: WuXi Bio +4.4%, Pharmaron +7.9%
- Semis lagged all session; the Kingboard complex stayed pinned in oversold territory
Today's Watchlist
- PLTR posted $0.41 EPS vs $0.28 est., revenue +92.8% after the close
- SNDK reports FQ4 on 8/5, right after defending the $1,000 shelf
- WuXi AppTec's H-shares spiked more than 14% intraday on 8/4
- ATKR agreed to Prysmian's $95/share all-cash bid; the arb spread has narrowed
- If AZN/BMY advances, antitrust review is the dominant variable
- Memory inflation cuts both ways: a tailwind for MU/SNDK, a headwind for AAPL
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (6 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
| CCRTOUS | $21.37 | -2.06% | 5 | Neutral | Down 2.06% on 12.77x relative volume — an unusual high-volume decline — with RSI neutral at 52.6 and no structural narrative in adtech; sidelines. |
 BOWUS | $33.69 | +10.13% | 5 | Neutral | Up 10.13% on 10.42x volume toward its 52-week high with RSI at 66.0, but the specialty-insurance small cap lacks verifiable follow-through; sidelines. |
 LIFEUS | $22.83 | +11.80% | 4 | Neutral | Up 11.8% on 3.86x volume and 20.9% for the week with RSI(7) extremely overbought at 80.7 — a recent listing without a 200-day reference; sidelines. |
 STOKUS | $29.56 | +2.43% | 4 | Neutral | Up 2.43% on unusual 5.27x volume with RSI neutral at 47.3 after a 9.7% monthly decline; clinical-stage biotech with no fundamental anchor; sidelines. |
 PLOWUS | $42.03 | -4.76% | 4 | Neutral | Down 4.76% on 3.37x volume with RSI weakening to 36.8 after a 19.4% month; seasonal snow-equipment demand hasn't started; sidelines. |
 CCOUS | $2.42 | +0.00% | 4 | Neutral | Flat at $2.42 on unusual 3.09x volume with RSI neutral at 55.3, just 0.8% off its 52-week high; a low-priced name with no margin of safety; sidelines. |